CD33, CD123, CLL1, TIM3, and CD244 are ubiquitously expressed on AML bulk cells and, often, in leukemic stem cells (LSCs), both at diagnosis and relapse, irrespective of genetic characteristics and leukemic clonal evolution. This evidence concerns the gene HAVCR2 and acute myeloid leukemia.